The FACIS fully automated test system offers all laboratories the opportunity to bring β-D-Glucan and Galactomannan tests in-house with a TAT of under 1 hour and a technical simplicity previously lacking in these tests.
FACIS provides Clinicians with almost immediate test results and the opportunity to reduce empiric antifungal therapy.
FACIS provides Clinicians with almost immediate test results and the opportunity to reduce empiric antifungal therapy.
Bringing Fungal Diagnostics In-House
|
The introduction of Beta D Glucan & Galactomannan are key fungal biomarkers but complex kit protocols and the cost/test of low sample numbers have limited the adoption of these tests in-house. Referring samples builds in delays and costs.
Both costs/test and complexity issues have been removed by the introduction of a fully automated system - FACIS |
|
Empiric antifungal therapy is what happens whilst you wait for lab test results
Because of Beta-D Glucans very high negative predictive value it plays a key role in guiding empiric therapy. Unfortunately these test results are often not available until dys after commencement of emperic therapy.
The FACIS system enbles all laboratories to offer a same day service. The test takes under 1 hour in the laboratory requiring minimal technical training making a 24/7 service posible.
The FACIS system enbles all laboratories to offer a same day service. The test takes under 1 hour in the laboratory requiring minimal technical training making a 24/7 service posible.
Antifungal Stewardship needs rapid diagnostics
Invasive Fungal infections (IFI) are less prevelant than bacterial infections, but their health and financial burden are substancial and increasing. As the use of antifugals for treatment and prophylaxis increases so the risk of resistance increases.
Diagnostic Gap Analysis against the BSMM Best Practice Guidelinesis an auditable aspect of Antifungal stewardship. 'The lack of available diagnostic tests and the time it takes to turn around the diagnostic tests that are available have been particularly challenging.'
Diagnostic Gap Analysis against the BSMM Best Practice Guidelinesis an auditable aspect of Antifungal stewardship. 'The lack of available diagnostic tests and the time it takes to turn around the diagnostic tests that are available have been particularly challenging.'
The FACIS fully automated β-D-Glucan test is a modified amaebolysate test utilising chemiluminescence. It is simple to use and has a cost per sample of £20 for one or many samples.
For more information on FACIS & β-D-Glucan follow this link
For more information on FACIS & β-D-Glucan follow this link
